Skip to main content
Premium Trial:

Request an Annual Quote

Nebula Genomics Raises $4.3M, Partners With Veritas

NEW YORK (GenomeWeb) – Nebula Genomics has raised $4.3 million in seed financing from venture capital firms and has also partnered with Veritas Genetics, the company said on Wednesday. 

Nebula, which was founded last year by Harvard University researchers including George Church, aims to build a platform on which genomic data can be shared by harnessing blockchain technology.

The startup secured funding from Khosla Ventures, Arch Venture Partners, Fenbushi Capital, Mayfield, F-Prime Capital Partners, Great Point Ventures, Windham Venture Partners, Hemi Ventures, Mirae Asset, Hikma Ventures, and Heartbeat Labs, and plans to use the financing to continue building a decentralized marketplace for genomic data.

Under the partnership with Veritas, Nebula will have access to Veritas' open-source software platform, Arvados.

"Our investors, along with Veritas, share our commitment to lowering access barriers to genomic data, and solving one of the primary roadblocks preventing personalized medicine becoming a reality today," Kamal Obbad, CEO and co-founder of Nebula Genomics, said in a statement. 

The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Target Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.